Drug · DIN 02426811
ASA EC
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since November 6, 2025; first marketed July 25, 2014.
- Drug Identification Number (DIN)
- 02426811
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet (Delayed-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Acetylsalicylic acid B01AC06
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ACETYLSALICYLIC ACID | 81 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 22, 2022: NOC 29785Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling update to match licensor
- August 18, 2022: NOC 28782Supplement to an Abbreviated New Drug Submission (SANDS) · Administrative: Labelling Update (to Match Licensor)
- January 23, 2020: NOC 23139Supplement to an Abbreviated New Drug Submission (SANDS) · Change in product ownership
- July 24, 2014: NOC 15875Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies